ArticleTheranostics2026

Intra-arterial peptide receptor radionuclide therapy (IA-PRRT) in patients with SSTR-expressing neuroendocrine neoplasms: short- and long-term safety and efficacy for up to 13 years.

Jingjing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.